Recombinant corynebacterium glutamicum for producing lysine by biofilm continuous fermentation and construction method thereof

    公开(公告)号:US11118171B2

    公开(公告)日:2021-09-14

    申请号:US17117870

    申请日:2020-12-10

    Abstract: The invention discloses a recombinant Corynebacterium glutamicum for producing lysine by biofilm continuous fermentation and a construction method thereof, wherein the recombinant Corynebacterium glutamicum is constructed by overexpressing a protease gene FtsH in a Corynebacterium glutamicum; and the construction method comprises the following steps of: (1) performing PCR on a genome of the Corynebacterium glutamicum, and amplifying the FtsH gene to obtain an amplified FtsH gene segment; (2) cloning the FtsH gene segment to an overexpression plasmid to obtain a recombinant plasmid; and (3) introducing the recombinant plasmid into the Corynebacterium glutamicum, and screening to obtain the recombinant Corynebacterium glutamicum. The invention has the beneficial effects that the Corynebacterium glutamicum for overexpressing the protease FtsH is constructed in the invention, and a film-forming ability of the Corynebacterium glutamicum is enhanced, such that a yield of continuous immobilized fermentation of the Corynebacterium glutamicum is increased by 38.2% than that of free fermentation of an original bacterium, and a fermentation cycle is shortened by 26.4%.

    Cordycepin-based derivatized compound with anti-tumor effect

    公开(公告)号:US12215123B2

    公开(公告)日:2025-02-04

    申请号:US18505822

    申请日:2023-11-09

    Abstract: A cordycepin-based derived compound with an anti-tumor effect, and a structure of the compound is as shown in formula I; a cordycepin derivative and a pharmaceutical composition thereof provided by the invention have a good anti-tumor proliferation effect; compared with a parent drug, the cordycepin derivative has better affinity to cell membranes, so that a half-life period of in-vivo metabolism of the drug is longer, and in-vivo remaining time of the drug is longer; compared with other nucleoside anti-tumor drugs, the cordycepin derivative and the pharmaceutical composition thereof provided by the invention have wider types and action ranges of tumors, have excellent inhibition effects on a gastric cancer, a pancreatic cancer, a liver cancer, a small cell lung cancer, a colorectal cancer, melanoma, an ovarian cancer and the like, and have lower side effects and better curative effects.

    RECOMBINANT CORYNEBACTERIUM GLUTAMICUM FOR PRODUCING LYSINE BY BIOFILM CONTINUOUS FERMENTATION AND CONSTRUCTION METHOD THEREOF

    公开(公告)号:US20210155917A1

    公开(公告)日:2021-05-27

    申请号:US17117870

    申请日:2020-12-10

    Abstract: The invention discloses a recombinant Corynebacterium glutamicum for producing lysine by biofilm continuous fermentation and a construction method thereof, wherein the recombinant Corynebacterium glutamicum is constructed by overexpressing a protease gene FtsH in a Corynebacterium glutamicum; and the construction method comprises the following steps of: (1) performing PCR on a genome of the Corynebacterium glutamicum, and amplifying the FtsH gene to obtain an amplified FtsH gene segment; (2) cloning the FtsH gene segment to an overexpression plasmid to obtain a recombinant plasmid; and (3) introducing the recombinant plasmid into the Corynebacterium glutamicum, and screening to obtain the recombinant Corynebacterium glutamicum. The invention has the beneficial effects that the Corynebacterium glutamicum for overexpressing the protease FtsH is constructed in the invention, and a film-forming ability of the Corynebacterium glutamicum is enhanced, such that a yield of continuous immobilized fermentation of the Corynebacterium glutamicum is increased by 38.2% than that of free fermentation of an original bacterium, and a fermentation cycle is shortened by 26.4%.

Patent Agency Ranking